ArticleOncoTargets and therapy2016

Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma.

Hai-Ying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.